Eddit

Aus coViki
(Unterschied zwischen Versionen)
Wechseln zu: Navigation, Suche
 
(133 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt)
Zeile 1: Zeile 1:
 
__NOTOC__
 
__NOTOC__
 
*'''[[Further reading]]'''
 
*'''[[Further reading]]'''
 +
  
 
*'''[[Unproven ideas]]'''
 
*'''[[Unproven ideas]]'''
  
 
*'''[[Reviews on covid19 disease]]'''
 
*'''[[Reviews on covid19 disease]]'''
{{tp|p=32020915|t=2020. The Novel Coronavirus: A Bird s Eye View |pdf=|usr=}}
+
*'''[[Clinical guidelines and advice]]'''
{{tp|p=32112977|t=2020. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |pdf=|usr=}}
+
{{tp|p=32125458|t=ä. COVID-19: a novel coronavirus and a novel challenge for critical care |pdf=|usr=}}
+
  
  
  
----
+
*'''[[Respiration mgmt]]'''
  
 +
*'''[[Diagnosis (Laboratory)]]'''
  
*'''[[Structure of covid19]]'''
 
  
*'''[[Target binding and uptake]]'''
+
*'''[[Diagnosis (Lung CT, Sonography)]]'''
{{tp|p=32344526|t=2020. COVID-19 and RAS: Unravelling an Unclear Relationship |pdf=|usr=}}
+
  
 +
*'''[[Diagnosis (other modalities)]]'''
  
  
*'''[[Cytopathic effects]]'''
 
  
 +
 +
*'''[[Structure of covid19]]'''
 +
 +
 +
*'''[[Target binding and uptake]]'''
 +
*'''[[Cytopathic effects]]'''
 
*'''[[Secretion and shedding]]'''
 
*'''[[Secretion and shedding]]'''
 +
 +
  
 
*'''[[Innate sensing]]'''
 
*'''[[Innate sensing]]'''
Zeile 30: Zeile 36:
  
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
 
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]'''
{{tp|p=32334118|t=ä. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 |pdf=|usr=}}
 
  
  
----
 
  
 +
*'''[[Pathobiology]]'''
  
*'''[[Early symptoms]]'''
 
  
*'''[[Systemic disease, any manifestations]]'''
+
*'''[[Disease Models]]'''
  
*'''[[Co-Infection]]'''
 
  
*'''[[ARDS]]'''
+
*'''[[Similar diseases and pathomechanisms]]'''
  
*'''[[Pulmonary embolism, coagulation]]'''
 
  
  
*'''[[Hematology]]'''
 
  
*'''[[Microvascular]]'''
+
*'''[[Early symptoms]]'''
  
*'''[[Heart]]'''
+
*'''[[Systemic disease, any manifestations]]'''
  
*'''[[Neurology, ophthalmology, orl]]'''
+
*'''[[Co-Infection]]'''
{{tp|p=32251791|t=2020. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 |pdf=|usr=}}
+
{{tp|p=32314322|t=ä. COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights |pdf=|usr=}}
+
  
  
*'''[[Dermatology]]'''
+
*'''[[Pulmonary embolism, coagulation]]'''
  
*'''[[Gastroenterology, hepatology]]'''
 
  
*'''[[Kidney, urology]]'''
 
  
----
 
  
  
*'''[[Pathobiology]]'''
+
*'''[[Hematology]]'''
{{tp|p=32094336|t=2020. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa |pdf=|usr=}}
+
  
  
*'''[[Disease Models]]'''
 
  
*'''[[Similar diseases and pathomechanisms]]'''
+
*'''[[Heart]]'''
----
+
  
  
*'''[[Diagnosis (Laboratory)]]'''
 
{{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
 
  
 +
*'''[[Neurology, ophthalmology, orl]]'''
  
  
*'''[[Diagnosis (Lung CT, Sonography)]]'''
 
  
 +
*'''[[Dermatology]]'''
  
  
  
*'''[[Diagnosis (other modalities)]]'''
+
*'''[[Gastroenterology, hepatology]]'''
{{tp|p=32344326|t=2020. COVID-19 and malaria: A symptom screening challenge for malaria endemic countries |pdf=|usr=}}
+
  
 +
*'''[[Kidney, urology]]'''
  
*'''[[Respiration mgmt]]'''
+
*'''[[The morbid survivor]]'''
{{tp|p=32251794|t=2020. Extracorporeal membrane oxygenation (ECMO): does it have a role in the treatment  of severe COVID-19?|pdf=|usr=}}
+
  
 +
*'''[[Risk and special populations]]'''
  
*'''[[Clinical guidelines and advice]]'''
 
  
*'''[[Risk and special populations]]'''
+
 
{{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than  males?|pdf=|usr=}}
+
*'''[[Case reports]]'''
{{tp|p=32222883|t=ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection |pdf=|usr=}}
+
{{tp|p=32125452|t=ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of  150 patients from Wuhan, China |pdf=|usr=}}
+
  
  
  
  
*'''[[The morbid survivor]]'''
 
  
  
*'''[[Case reports]]'''
 
  
 
*'''[[Case series]]'''
 
*'''[[Case series]]'''
Zeile 114: Zeile 101:
  
 
*'''[[Registries]]'''
 
*'''[[Registries]]'''
----
 
  
  
 
*'''[[Trials]]'''
 
*'''[[Trials]]'''
{{tp|p=32290293|t=2020. A Review of SARS-CoV-2 and the Ongoing Clinical Trials |pdf=|usr=}}
 
 
  
 
*'''[[Candidate Compounds Covid19]]'''
 
*'''[[Candidate Compounds Covid19]]'''
{{tp|p=32368489|t=2020. The pathogenesis and alternative treatment of SARS-CoV2 |pdf=|usr=}}
 
{{tp|p=32289016|t=2020. Herbal medicine and pattern identification for treating COVID-19: a rapid review  of guidelines |pdf=|usr=}}
 
{{tp|p=32125455|t=ä. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |pdf=|usr=}}
 
{{tp|p=32347443|t=ä. Camostat mesilate therapy for COVID-19 |pdf=|usr=}}
 
  
  
 
+
*'''[[Other routes of infection]]'''
----
+
  
  
 
*'''[[Biophysics of aerosols]]'''
 
*'''[[Biophysics of aerosols]]'''
{{tp|p=32340347|t=2020. Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough |pdf=|usr=}}
 
  
*'''[[Other routes of infection]]'''
 
{{tp|p=32335340|t=ä. Potential Fecal Transmission of SARS-CoV-2: Current Evidence and Implications for Public Health |pdf=|usr=}}
 
  
 
 
*'''[[Remission, recurrence and persistence]]'''
 
{{tp|p=32200109|t=2020. SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern  regarding the present standard for discharge |pdf=|usr=}}
 
{{tp|p=32251796|t=ä. The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of isolation?|pdf=|usr=}}
 
{{tp|p=32147538|t=2020. Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report |pdf=|usr=}}
 
  
  
 
*'''[[Passive protective equipment]]'''
 
*'''[[Passive protective equipment]]'''
{{tp|p=32325718|t=2020. Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of Healthcare Workers in Latin America |pdf=|usr=}}
 
{{tp|p=32334119|t=ä. Addressing the corona virus outbreak: will a novel filtered eye mask help?|pdf=|usr=}}
 
{{tp|p=32203757|t=2020. Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19) |pdf=|usr=}}
 
{{tp|p=32265088|t=ä. Custom-made 3D-printed face masks in case of pandemic crisis situations with a lack of commercially available FFP2/3 masks |pdf=|usr=}}
 
  
  
Zeile 157: Zeile 123:
  
  
 +
*'''[[Mental aspects of health professionals]]'''
  
----
+
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
  
  
*'''[[Mental aspects of health professionals]]'''
 
  
 
*'''[[Socio-psychiatric aspects of the status hygienicus]]'''
 
  
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 
*'''[[Avoiding clinical medicine in other diseases]]'''
 +
 +
  
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 
*'''[[Occupational medicine, workplace security and status hygienicus]]'''
 +
  
 
*'''[[Economic aspects of the status hygienicus]]'''
 
*'''[[Economic aspects of the status hygienicus]]'''
{{tp|p=32325710|t=2020. The COVID-19 Outbreak and Affected Countries Stock Markets Response |pdf=|usr=}}
 
{{tp|p=32305533|t=ä. The Socio-Economic Implications of the Coronavirus and COVID-19 Pandemic: A Review |pdf=|usr=}}
 
  
  
Zeile 180: Zeile 145:
  
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
*'''[[Host, vector, one health, atmospheric aspects]]'''
 
  
 
*'''[[Origin of Covid19]]'''
 
*'''[[Origin of Covid19]]'''
  
 
*'''[[Epidemiology]]'''
 
*'''[[Epidemiology]]'''
{{tp|p=32225178|t=2020. The Impact of COVID-19 on Italy: A Lesson for the Future |pdf=|usr=}}
 
{{tp|p=32218558|t=2020. Preparedness and Lessons Learned from the Novel Coronavirus Disease |pdf=|usr=}}
 
{{tp|p=32271914|t=ä. The hearth of mathematical and statistical modelling during the Coronavirus pandemic |pdf=|usr=}}
 
{{tp|p=32123989|t=ä. The novel coronavirus (SARS-CoV-2) infections in China: prevention, control and challenges |pdf=|usr=}}
 
  
  
  
*'''[[Failure of politics and public health guidance]]'''
+
 
 +
 
 +
*'''[[Remission, recurrence and persistence]]'''
 +
 
 +
 
  
 
*'''[[Failure of executive measures]]'''
 
*'''[[Failure of executive measures]]'''
 
----
 
----
 +
*'''[[Failure of politics and public health guidance]]'''
  
  
 
*'''[[Political abuse of Covid19]]'''
 
*'''[[Political abuse of Covid19]]'''
{{tp|p=32316647|t=2020. Using Social Media to Mine and Analyze Public Opinion Related to COVID-19 in China |pdf=|usr=}}
+
 
*[https://www.businessinsider.com/nearly-half-of-reopen-america-twitter-accounts-are-bots-report-2020-5?utmSource=twitter&utmContent=referral&utmTerm=topbar&referrer=twitter twitter botwar]
+
  
  
 
*'''[[Lost people]]'''
 
*'''[[Lost people]]'''
{{tp|p=32142979|t=2020. Li Wenliang, a face to the frontline healthcare worker  The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak |pdf=|usr=}}
 
  
 
*'''[[Lost civilization]]'''
 
*'''[[Lost civilization]]'''
 +
 
----
 
----
  
  
 
*'''[[History of covid19 exploration]]'''
 
*'''[[History of covid19 exploration]]'''
 
 
*'''[[misc.]]'''
 
*'''[[misc.]]'''
{{tp|p=32175070|t=2020. Positive Screening for Wuhan Novel Coronavirus Infection at International Airport: What s the Final Diagnosis for Positive Cases |pdf=|usr=}}
 
{{tp|p=32372270|t=ä. Three further ways that the COVID-19 pandemic will affect health outcomes |pdf=|usr=}}
 
{{tp|p=32307030|t=ä. The fight against COVID-19: a report from the Italian trenches |pdf=|usr=}}
 
  
  
 
*'''[[Research tools]]'''
 
*'''[[Research tools]]'''
 +
 +
 +
 +
 +
{{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}}
 +
{{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}}
 +
 +
 +
*'''[[PrePrint scene]]'''
 +
  
 
*'''[[from the ads]]'''
 
*'''[[from the ads]]'''
  
 
*'''[[Current state of coviki.org]]'''
 
*'''[[Current state of coviki.org]]'''
 +
*'''[[on-topic personal thoughts]]'''

Aktuelle Version vom 7. Juni 2020, 22:19 Uhr



















































27490990 2017. AVCpred: an integrated web server for prediction and design of antiviral compounds
25040500 2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system



Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge
Blogverzeichnis - Blog Verzeichnis bloggerei.deBlogverzeichnis